New Alzheimer’s Trial Data; Microbiome and MS; Monkeypox’s Neuro…
The oral beta-amyloid blocker ALZ-801 (valiltramiprosate) reduced plasma phosphorylated tau…
Browsing Tag
neuro
ClearPoint Neuro Announces FDA Clearance for ClearPoint Maestro™ Brain Model
SOLANA BEACH, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…
ClearPoint Neuro Reports Second Quarter 2022 Results
SOLANA BEACH, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…
ClearPoint Neuro félicite son partenaire PTC Therapeutics pour l’obtention de…
La première thérapie génique approuvée pour une perfusion directe dans le cerveau sera administrée avec la canule neurologique SmartFlow® de ClearPoint SOLANA BEACH, Californie, 22 juill.…
ClearPoint Neuro beglückwünscht Partner PTC Therapeutics für den Erhalt der…
Die erste zur direkten Infusion in das Gehirn zugelassene Gentherapie wird mit der SmartFlow® Neurokanüle von ClearPoint verabreicht SOLANA BEACH, Kalifornien, July 22, 2022 (GLOBE…
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing…
SOLANA BEACH, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…
Neuro Symptoms of Long COVID May Persist for Months
Robert Preidt
MONDAY, June 20, 2022 (HealthDay News) -- Many COVID-19 long-haulers still have neurological symptoms such as headaches, fatigue and…
ClearPoint Neuro Announces Receipt of MDSAP Certification
SOLANA BEACH, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP…
SOLANA BEACH, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery…
ClearPoint Neuro Expands Software License and Research Agreement with Philips to…
SOLANA BEACH, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and…